Published in Gastroenterology Week, June 18th, 2007
“Taking gender into account when examining the genetic profile of patients may help to those who will benefit from specific chemotherapy treatments,” says principal investigator Heinz-Josef Lenz, M.D., professor of medicine at USC’s Keck School of Medicine.
Findings from the study were displayed on Monday, June 4 at the annual meeting of the American Society of Clinical Oncology (ASCO) held at McCormick Place in Chicago.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.